CSNK1A1 and colorectal cancer: In addition, one study indicated that targeting CK1α can increase the sensitivity of colorectal cancer cells to 5-FU via the Wnt signaling pathway, G2 and S phase arrests, G1 arrest, reduction of ABCG2 mRNA, and inhibition of autophagy flux, potentially enhancing colon cancer treatment strategies [34].